COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

Affiliations

¹ Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA peramire@mdanderson.org.
² Obstetrics and Gynecology, Clinica Universidad de Navarra, MADRID, Spain.
³ Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway.
⁴ Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Woman and Child's Health Department, Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Roma, Italy.
⁶ Medical Oncology, Clinica Universidad de Navarra, Madrid, Madrid, Spain.
⁷ Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
⁸ Gynecologic Oncology, Clinica ASTORGA, Medellin, Colombia.
⁹ Instituto Nacional de Cancerología, Bogotá, Colombia.

Free article

Editorial

Pedro T Ramirez et al. Int J Gynecol Cancer. 2020 May.

Free article

. 2020 May;30(5):561-563.

doi: 10.1136/ijgc-2020-001419. Epub 2020 Mar 27.

¹ Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA peramire@mdanderson.org.
² Obstetrics and Gynecology, Clinica Universidad de Navarra, MADRID, Spain.
³ Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway.
⁴ Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Woman and Child's Health Department, Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Roma, Italy.
⁶ Medical Oncology, Clinica Universidad de Navarra, Madrid, Madrid, Spain.
⁷ Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
⁸ Gynecologic Oncology, Clinica ASTORGA, Medellin, Colombia.
⁹ Instituto Nacional de Cancerología, Bogotá, Colombia.

No abstract available

Keywords: cervical cancer; ovarian cancer; pathology; radiation; surgery.

Conflict of interest statement

Competing interests: None declared.

COVID-19 global pandemic: options for management of gynecologic cancers. The experience in surgical management of ovarian cancer in the second highest affected Italian region.
Perrone AM, De Palma A, De Iaco P. Perrone AM, et al. Int J Gynecol Cancer. 2020 Jun;30(6):902. doi: 10.1136/ijgc-2020-001489. Epub 2020 May 6. Int J Gynecol Cancer. 2020. PMID: 32381511 No abstract available.
Surviving the COVID-19 pandemic: early response of a gynecologic oncology unit in Singapore.
Lim YH, Chay WY, Wong WL. Lim YH, et al. J Gynecol Oncol. 2020 Nov;31(6):e77. doi: 10.3802/jgo.2020.31.e77. J Gynecol Oncol. 2020. PMID: 33078587 Free PMC article. No abstract available.